ASCO: One step closer to a breath test for lung cancer

(University of Colorado Denver) Results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology show that a test of organic compounds in exhaled breath can not only distinguish patients with lung cancer from patients with chronic obstructive pulmonary disease, but can also define the stage of any cancer present.